COPEDOL: A two-year observational study in pretreated HIV-1-infected patients switching to a dolutegravir-based regimen
{{output}}
Objectives: Dolutegravir is a second-generation integrase strand transfer inhibitor of particular interest as a rescue treatment for people living with HIV (PLWHIV) who develop resistance to multiple antiretrovirals (ART). We ass... ...
